Señales en vivo de SAVAW | Maximiza tus Ganancias con Getagraph.com

COMPRAR 140236 min ago

@ $7.14

Emitido: 12 feb 2024 @ 09:30

Retorno: -99.58%

Señal anterior: feb 6 - 14:44

Señal anterior: Vender

Retorno: -3.12 %

Live Chart Being Loaded With Signals

Commentary (2 may 2024 @ 16:00):

Stats
Volumen de hoy	2.51M
Volumen promedio	331 000
Capitalización de mercado	1.44M
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00400 (15.38%)

Volumen Correlación

Largo: -0.04 (neutral)

Corto: -0.88 (strong negative)

Signal:(45.286) Neutral

Cassava Sciences, Inc. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cassava Sciences, Inc. Correlación - Moneda/Commodity

-0.28
( neutral )

-0.51
( weak negative )

0.00
( neutral )

0.14
( neutral )

Financial Reports:

No articles found.

Cassava Sciences, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cassava Sciences, Inc.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.